Mabel Rodriguez

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency*

S. Devlin, A. Lesokhin, A. Ogunniyi, 2017, Leukemia & lymphoma.

Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat

O. Landgren, N. Lendvai, A. Michael, 2015, Pharmacotherapy.

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma

M. Piris, D. Martín-Pérez, J. Bischoff, 2010, Haematologica.

Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies

Troy Z. Horvat, Amber C King, Mabel Rodriguez, 2017, The Annals of pharmacotherapy.

Ziv-Aflibercept Use in Metastatic Colorectal Cancer

Mabel Rodriguez, 2013, Journal of the advanced practitioner in oncology.

Giant cell arteritis in a Hispanic population.

C. Juárez, V. Reviglio, J. Luna, 2002, Ophthalmology (Rochester, Minn.).